Charting a path to growth has been saved
Charting a path to growth
Helping Bayer Consumer Health to define a consumer and marketing strategy for global expansion
In 2014, Bayer Consumer Health (BCH) acquired Merck’s consumer health business. The acquisition steered BCH into unchartered territory, bringing four new product categories into its portfolio, so it turned to Deloitte for help in defining a consumer and marketing strategy.
Using its market-leading Growthpath® methodology, Deloitte successfully supported BCH in charting a path to long-term, sustainable growth and competitive advantage. As a result, BCH’s international Category leaders and Marketing Directors developed customer-led strategies, making clear ‘Where-to-Play’ and ‘How-to-Win’ choices, and identifying significant growth upside from the acquisition.